SCHEMBL6521606

SCHEMBL6521606

NC(=O)c1cccc(CNc2ccc3c(=O)[nH]c4ncccc4c3c2)c1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RPS6KB1 P23443 6/20 0.47
AURKA O14965 5/20 0.47
AURKB Q96GD4 3/20 0.47
PARP1 P09874 1/20 0.46
VNN1 O95497 1/20 0.43
CLK1 P49759 1/20 0.42
PRKCI P41743 1/20 0.42
CCNT1 O60563 1/20 0.41
CDK9 P50750 1/20 0.41
CAMKK2 Q96RR4 1/20 0.41
MRGPRX4 Q96LA9 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP19A1 P11511 1/20 0.40
IP6K1 Q92551 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
PDPK1 O15530 1/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6521530 0.88 HIF1A (0.51) AURKAPARP1CCNT1CDK9CNR1
SCHEMBL3454371 0.83 AURKA (0.60) RPS6KB1AURKAAURKBPARP1CDK9
SCHEMBL6523494 0.83 AURKA (0.50) RPS6KB1AURKAPARP1CCNT1CDK9
SCHEMBL6519127 0.83 CDC7 (0.51) RPS6KB1AURKAPARP1CLK1CCNT1
SCHEMBL6517978 0.83 CDC7 (0.52) AURKAPARP1CYP1A2CYP3A4IP6K1
SCHEMBL12846396 0.82 PARP1 (0.49) AURKAPARP1CLK1CCNT1CDK9
SCHEMBL6522983 0.82 PARP1 (0.49) AURKAPARP1CAMKK2IP6K1HDAC6
SCHEMBL6516089 0.81 AURKA (0.54) AURKAPARP1CCNT1CDK9CYP1A2
SCHEMBL6517544 0.80 FGFR1 (0.51) AURKAPARP1CCNT1CDK9
SCHEMBL6517545 0.80 LRRK2 (0.53) AURKAPARP1VNN1CCNT1CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
EP-2254889-B1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2012-12-19 EP disclosed
EP-2254889-B1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2012-12-19 EP disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
WO-2009108670-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK SERONO S.A. (CH) 2009-09-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MAP4K2, MAP3K20, MAP4K1 RPS6KB1 200/4885AURKA 538/4885AURKB 487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.